AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Cronos Group Inc (NASDAQ:CRON)
1.96 USD
+0.050 2.618%Sponsored Reports
Loading...
| Previous Close (in USD) | 1.91 |
|---|---|
| Change | +0.050 2.618% |
| 52 W H/L (in USD) | 3.140/1.640 |
| EBITDA (in USD) | -66.249M |
| PE Ratio | -- |
| Volume | 3005247 |
| Diluted Eps TTM | -0.14 |
| Total Assets (in USD) | 1134.252M |
|---|---|
| Total Liabilities (in USD) | 43.736M |
| Revenue TTM (in USD) | 93.034M |
| Cash (in USD) | 665.867M |
| Market Cap (in USD) | 1,024.883 M |
| Revenue Per Share TTM | 0.244 |
| Gross Profit TTM (in USD) | 11.969M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Cronos Group Inc
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Employees: 356
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Michael Ryan Gorenstein J.D. | Pres, CEO & Chairman | 1987 |
| 2. | Ms. Shannon Buggy | Sr. VP & Global Head of People | 1970 |
| 3. | Ms. Anna Shlimak | Sr. VP of Corp. Affairs & Strategy | 1986 |
| 4. | Mr. James Holm | Chief Financial Officer | NA |
| 5. | Mr. Carlos Cortez | VP, Controller & Principal Accounting Officer | 1973 |
| 6. | Mr. Shayne J. Laidlaw | Director of Investor Relations & Strategy | NA |
| 7. | Mr. Terry Gregory-Joseph Doucet | Sr. VP of Legal & Regulatory Affairs and Corp. Sec. | 1990 |
| 8. | Mr. Jeffrey David Jacobson | Chief Growth Officer | 1986 |
| 9. | Mr. Arye Weigensberg | Head of R&D | NA |
| 10. | Mr. Kevin B Gifford | VP of Fin. | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
+0.918 0.545% | 169.58 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
-0.110 0.417% | 26.35 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
+1.260 0.949% | 130.195 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
TAK
Takeda Pharmaceutical Co Ltd ADR |
-0.051 0.341% | 14.92 | 32.670 | 11.534 | 0.011 | 0.874 | 0.018 | 0.069 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -134.559M | -397.135M | -73.273M | 1165.574M | -13.741M |
| Minority Interest | 0M | -1.097M | -2.133M | -0.853M | 0.1M |
| Net Income | -168.734M | -396.704M | -74.62M | 2455.376M | -13.928M |
| Selling General Administrative | 86.293M | 106.633M | 95.89M | 60.991M | 15.902M |
| Gross Profit | 11.969M | -17.534M | -25.833M | -17.864M | 8.273M |
| Reconciled Depreciation | 13.122M | 15.402M | 7.045M | 3.913M | 1.843M |
| Ebit | -116.012M | 6.785M | -179.347M | -121.484M | -13.457M |
| Ebitda | -59.185M | 22.187M | -160.085M | -1405.339M | -11.614M |
| Depreciation And Amortization | 56.827M | 15.402M | 19.262M | -1283.855M | 1.843M |
| Operating Income | -116.012M | 6.785M | -179.347M | -121.484M | -13.295M |
| Other Operating Expenses | 207.916M | 271.354M | 226.066M | 139.906M | 24.824M |
| Interest Expense | 22.537M | 0.027M | 0.186M | 27.982M | 0.079M |
| Tax Provision | 34.175M | -0.431M | 1.347M | 0M | 0.359M |
| Interest Income | 22.537M | 9.098M | 18.601M | 1271.528M | 0.476M |
| Net Interest Income | 22.537M | 9.071M | 18.375M | -4.226M | 0.079M |
| Income Tax Expense | 34.175M | -0.431M | 1.347M | -1289.802M | 0.359M |
| Total Revenue | 91.904M | 74.435M | 46.719M | 23.75M | 11.529M |
| Total Operating Expenses | 127.981M | 179.385M | 153.514M | 98.292M | 21.568M |
| Cost Of Revenue | 79.935M | 91.969M | 72.552M | 41.614M | 3.256M |
| Total Other Income Expense Net | -18.547M | -403.92M | 106.074M | 1287.058M | -0.525M |
| Net Income From Continuing Ops | -168.734M | -396.704M | -74.62M | 1165.574M | -14.1M |
| Net Income Applicable To Common Shares | -168.734M | -396.107M | -73.137M | 1166.506M | -21.636M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 1134.252M | 1213.009M | 1397.738M | 1925.682M | 2090.442M |
| Intangible Assets | 21.078M | 26.704M | 18.079M | 69.72M | 72.32M |
| Other Current Assets | 5.377M | 7.106M | 8.967M | 12.337M | 9.395M |
| Total Liab | 43.736M | 72.045M | 63.462M | 217.514M | 341.412M |
| Total Stockholder Equity | 1093.945M | 1143.885M | 1337.243M | 1711.364M | 1749.883M |
| Other Current Liab | 28.066M | 55.623M | 14.375M | 163.41M | 297.16M |
| Common Stock | 610.585M | 611.318M | 595.497M | 569.26M | 561.165M |
| Capital Stock | 613.725M | 611.318M | 595.497M | 569.26M | 561.165M |
| Retained Earnings | 414.587M | 490.682M | 659.416M | 1064.509M | 1137.646M |
| Good Will | 1.052M | 1.033M | 1.098M | 179.522M | 214.794M |
| Other Assets | 0M | 72.538M | 80.735M | 116.669M | 64.404M |
| Cash | 665.867M | 764.644M | 886.973M | 1078.023M | 1199.693M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 41.187M | 68.116M | 54.373M | 206.834M | 332.888M |
| Current Deferred Revenue | 0.064M | - | 26.069M | - | - |
| Net Debt | -663.327M | -760.768M | -877.167M | -1068.209M | -1192.586M |
| Short Term Debt | 0.989M | 1.33M | 2.711M | 1.322M | 0.427M |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 2.54M | 3.876M | 9.806M | 9.814M | 7.107M |
| Other Stockholder Equity | 48.201M | 42.682M | 32.465M | 34.596M | 23.234M |
| Property Plant Equipment | - | 62.83M | 82.952M | 187.599M | 166.494M |
| Total Current Assets | 928.531M | 960.156M | 1079.718M | 1372.172M | 1570.012M |
| Long Term Investments | 54.739M | 89.748M | 135.156M | 106.893M | 0.557M |
| Short Term Investments | 191.253M | 113.077M | 117.684M | 211.766M | 306.347M |
| Net Receivables | 35.694M | 37.77M | 33.292M | 26.044M | 16.534M |
| Long Term Debt | - | - | - | - | - |
| Inventory | 30.339M | 37.559M | 32.802M | 44.002M | 38.043M |
| Accounts Payable | 12.068M | 11.163M | 11.218M | 42.102M | 35.301M |
| Accumulated Other Comprehensive Income | 20.572M | -0.797M | 49.865M | 42.999M | 27.838M |
| Non Currrent Assets Other | 0.045M | 72.538M | 0.1M | 87.658M | 64.404M |
| Non Current Assets Total | 205.721M | 252.853M | 318.02M | 553.51M | 520.43M |
| Capital Lease Obligations | 2.553M | 3.876M | 9.806M | 9.814M | 7.107M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -1.842M | -14.699M | 50.752M | -359.905M | -5.091M |
| Total Cashflows From Investing Activities | -1.842M | -28.898M | 20.15M | -603.539M | -93.908M |
| Total Cash From Financing Activities | -2.897M | -13.442M | -5.465M | 1856.941M | 113.536M |
| Net Income | -168.734M | -397.204M | -75.27M | 1165.574M | -14.1M |
| Change In Cash | -122.329M | -191.05M | -121.67M | 1175.766M | 17.199M |
| Begin Period Cash Flow | 886.973M | 1078.023M | 1199.693M | 23.927M | 6.76M |
| End Period Cash Flow | 764.644M | 886.973M | 1078.023M | 1199.693M | 23.96M |
| Total Cash From Operating Activities | -88.948M | -153.616M | -142.457M | -130.007M | -7.15M |
| Depreciation | 13.122M | 15.402M | 7.045M | 3.913M | 1.843M |
| Other Cashflows From Investing Activities | 0.452M | 1.652M | 0.81M | -204.97M | -0.231M |
| Dividends Paid | 0.384M | - | - | - | 0M |
| Change To Inventory | -7.217M | 11.565M | -28.094M | 29.44M | -3.892M |
| Sale Purchase Of Stock | - | - | -1.019M | 1805.834M | 118.122M |
| Other Cashflows From Financing Activities | -2.513M | -13.442M | -3.051M | 1922.14M | 6.32M |
| Capital Expenditures | 5.032M | 12.262M | 35.391M | 38.953M | 84.262M |
| Change In Working Capital | 20.663M | -2.005M | -33.943M | -54.208M | 3.483M |
| Other Non Cash Items | 30.886M | -2.179M | -56.997M | 4.627M | -1.847M |
| Free Cash Flow | -93.98M | -165.878M | -177.848M | -168.96M | -91.412M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Amplify Alternative Harvest ETF | 1 year ago | 6596457 |
| 2. | Global X Marijuana Life Sciences ETF | 1 year ago | 3726208 |
| 3. | Vanguard Total Intl Stock Index Inv | 1 year ago | 2577810 |
| 4. | Vanguard Developed Markets Index Admiral | 1 year ago | 1626883 |
| 5. | Vanguard Instl Ttl Intl Stk Mkt Idx TrII | 1 year ago | 1297586 |
| 6. | AdvisorShares Pure Cannabis ETF | 1 year ago | 853404 |
| 7. | Vanguard FTSE All-Wld ex-US SmCp Idx Ins | 1 year ago | 709666 |
| 8. | Dimensional Canadian Small Company | 1 year ago | 659166 |
| 9. | DFA International Small Company I | 1 year ago | 637012 |
| 10. | DFA International Core Equity I | 1 year ago | 543483 |
| 11. | Amplify Seymour Cannabis ETF | 1 year ago | 524169 |
| 12. | USA Mutuals Vice Investor | 1 year ago | 480000 |
| 13. | State St Gbl Sm Cp Eq ex-US Indx NL Cl A | 1 year ago | 455101 |
| 14. | Vanguard FTSE Canada All Cap ETF | 1 year ago | 439408 |
| 15. | Schwab International Small-Cap Eq ETF™ | 1 year ago | 386650 |
| 16. | iShares Core MSCI Total Intl Stk ETF | 1 year ago | 386122 |
| 17. | DFA Canadian Core Equity Class F | 1 year ago | 384504 |
| 18. | iShares Core MSCI Intl Dev Mkts ETF | 1 year ago | 274969 |
| 19. | Fidelity Nasdaq Composite Index | 1 year ago | 260717 |
| 20. | Vitreo Canabidiol FIA IE | 1 year ago | 249350 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Group Inc | 1 year ago | 7090320 |
| 2. | Dimensional Fund Advisors, Inc. | 1 year ago | 2439314 |
| 3. | Two Sigma Investments LLC | 1 year ago | 1554745 |
| 4. | Susquehanna International Group, LLP | 1 year ago | 1357213 |
| 5. | Group One Trading, LP | 1 year ago | 1058718 |
| 6. | Millennium Management LLC | 1 year ago | 774030 |
| 7. | Mirae Asset Global Investments (Korea) Co Ltd | 1 year ago | 681414 |
| 8. | Renaissance Technologies Corp | 1 year ago | 668700 |
| 9. | Intact Investment Management, Inc. | 1 year ago | 607390 |
| 10. | Penserra Capital Management, LLC | 1 year ago | 595463 |
| 11. | AdvisorShares Investments, LLC | 1 year ago | 493404 |
| 12. | Kerrisdale Advisers, LLC | 1 year ago | 464042 |
| 13. | Swiss National Bank | 1 year ago | 415400 |
| 14. | Parallax Volatility Advisers, LLC | 1 year ago | 358109 |
| 15. | Goldman Sachs Group Inc | 1 year ago | 326602 |
| 16. | Morgan Stanley - Brokerage Accounts | 1 year ago | 323871 |
| 17. | CIBC World Markets Corp | 1 year ago | 304966 |
| 18. | Credit Suisse First Boston (CSFB) | 1 year ago | 271176 |
| 19. | Clarivest Asset Management LLC | 1 year ago | 265161 |
| 20. | Chescapmanager LLC | 1 year ago | 8327090 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...